GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By 2023,…
GLP-1 weight-loss drugs are one of the biggest biotech breakthroughs of the last decade. But to some clinical psychologists, they can represent something more sinister—a potential trigger for eating disorders. A new report suggests that the global incidence of anorexia nervosa and bulimia nervosa shot up between 1990 and 2023—by a whopping 71%. By 2023,…
<iframe src="https://statesidedaily.com/embed/cluster/f724eaf22bdd9c3a0f48aa558796ff1675391633" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Eating disorders are on the rise. GLP-1s could make things worse."></iframe>